VIDEREGEN
Videregen’s goal is to offer the world’s first commercially available organ replacement products to address the chronic shortage of organs for transplantation. Formed in 2011 as a spin-out from Northwick Park Institute of Medical Research in London, it uses its proprietary technology to produce biological scaffolds to which a patient’s own stem cells are added, creating a bespoke organ replacement. Initially focused on diseases of the trachea and bowel, Videregen aims to develop the world’s first commercially available organ replacements for these conditions, reducing healthcare costs and improving the quality of life for patients.
VIDEREGEN
Industry:
Biotechnology Health Care Medical Medical Device Pharmaceutical
Founded:
2011-01-01
Address:
Liverpool, Liverpool, United Kingdom
Country:
United Kingdom
Website Url:
http://www.videregen.com
Total Employee:
11+
Status:
Active
Contact:
+44 (0) 1514 829 350
Total Funding:
3.1 M GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Google Tag Manager WordPress Domain Not Resolving Apache Mobile Non Scaleable Content
Similar Organizations
Center of Regenerative Medicine
Center of Regenerative Medicine in Barcelona
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
Osciflex
Osciflex system imitates nature’s process to prevent deadly blood clots.
Portal Instruments
Portal Instruments is an early stage company that offers medical device.
Current Employees Featured
Steve Bloor Founder & CEO @ Videregen
Founder & CEO
2013-01-01
Doug Quinn CFO @ Videregen
CFO
2014-05-01
Paul Armitage Project Manager @ Videregen
Project Manager
2014-01-01
Founder
Investors List
The North West Fund
The North West Fund investment in Series A - Videregen
Deepbridge Capital
Deepbridge Capital investment in Series A - Videregen
Innovate UK
Innovate UK investment in Series A - Videregen
Newable Private Investing
Newable Private Investing investment in Series A - Videregen
Official Site Inspections
http://www.videregen.com
- Host name: speakeasy.enixvps.com
- IP address: 91.238.162.34
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
Videregen.com lookup results from whois.meshdigital.com server:
- Domain created: 14th-Jan-2011
- Domain updated: 15th-Jan-2025
- Domain expires: 14th-Jan-2026 0 Years, 277 Days left
- Website age: 14 Years, 88 Days
- Registrar Domain ID: 1635050658_DOMAIN_COM-VRSN
- Registrar Url: http://www.meshdigital.com
- Registrar WHOIS Server: whois.meshdigital.com
- Registrar Abuse Contact Email: abuse@domainbox.com
- Registrar Abuse Contact Phone: +18779770099
- Name server:
- NS67.1AND1.CO.UK
- NS68.1AND1.CO.UK